Ardent Health, Inc. reports developments for a healthcare provider serving growing mid-sized urban communities in the United States. Through its subsidiaries, the company operates acute care hospitals and other sites of care across six states, with recurring updates centered on patient volume, admissions, net patient service revenue, adjusted EBITDA, cash flow, guidance, and balance-sheet priorities.
Company news also covers management presentations at healthcare investor conferences, operational-efficiency initiatives such as the IMPACT program, payer and Exchange market dynamics, and technology investments in virtual care. Recent operating updates include enterprise use of AI-assisted virtual nursing, patient observation, and patient-safety monitoring to support clinical workflows across inpatient settings.
Ardent Health (NYSE: ARDT) reported strong Q4 2024 results, with total revenue growing 19.3% year-over-year to $1,606 million. The quarter was positively impacted by the New Mexico state directed payment program approval and recovery from a 2023 cybersecurity incident.
Key Q4 2024 metrics include:
- Net income of $114 million ($0.81 per diluted share) vs. net loss of $4 million in Q4 2023
- Adjusted EBITDA increased 213% to $183 million
- Admissions up 11.5% with strong growth in general medicine, cardiology and neurology
- Surgeries increased 6.3% year-over-year
For full-year 2024, revenue increased 10.3% to $5.97 billion, with Adjusted EBITDA growing 58.4% to $498 million. The company maintained strong liquidity with $557 million in cash and total debt of $1.1 billion. In January 2025, ARDT acquired 18 urgent care clinics from NextCare Urgent Care in New Mexico and Oklahoma.
Ardent Health (NYSE: ARDT), a leading healthcare provider in mid-sized urban communities across the U.S., announced participation in upcoming investor conferences.
The company will attend the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, in Miami, Florida. Ardent Health's management team will engage in a fireside chat at 8 a.m. ET.
Additionally, they will join the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025, with a fireside chat scheduled for 9 a.m. ET.
A live audio webcast of these presentations will be accessible on the company's Investor Relations website at https://ir.ardenthealth.com, with replays available for 90 days.
Ardent Health's management will also be available for one-on-one meetings with registered investors at each conference. For further details, investors can contact their sales representative at the host firm or reach out to Dave Styblo, Ardent Health's senior vice president of investor relations, at Investor.Relations@ardenthealth.com.
TruLite Health, developer of health equity solutions, has expanded its leadership team with key appointments. Walter D. Conwell, MD, MBA, former chief diversity officer at Morehouse School of Medicine, has been appointed as president. The company also added two board members: Edmondo Robinson, MD, MBA, a digital health leader and Ardent Health Services board member, and Caleb DesRosiers, JD, MPA, a pharmaceutical executive.
TruLite's main product, Truity™, is software that integrates with electronic health records to address clinical bias at the point of care. The solution uses explainable AI and machine learning to drive patient-specific clinical, social, and behavioral interventions, aiming to improve healthcare outcomes and costs. The software aligns with regulatory requirements from the Joint Commission, CMS, and FDA.
Ardent Health (NYSE: ARDT) has scheduled its fourth quarter and full year 2024 financial results announcement for Wednesday, February 26, 2025, after market close. The company will host a conference call and webcast on Thursday, February 27, 2025, at 9:00 a.m. ET to discuss the results and conduct a Q&A session.
The webcast and presentation materials will be accessible through Ardent's Investor Relations website at ir.ardenthealth.com. Participants are advised to register 15 minutes before the scheduled start time. The teleconference replay will be available until March 13, 2025, through both domestic and international dial-in numbers.
Ardent Health (NYSE: ARDT) has announced the acquisition of 18 urgent care clinics from NextCare Urgent Care, expanding its presence in New Mexico and Oklahoma. The transaction includes six clinics in New Mexico, which will operate under Lovelace Health System, and 12 clinics in Oklahoma under Hillcrest HealthCare System.
This strategic expansion enhances Ardent's consumer-focused healthcare ecosystem and follows their recent acquisition of nine urgent care centers in East Texas and Topeka, Kansas in 2024. The company currently operates five hospitals and 25 sites of care in New Mexico, along with eight hospitals and 57 sites of care in Oklahoma. The financial terms of the acquisition were not disclosed.
Ardent Health (NYSE: ARDT) has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 13-16, 2025. The company's management team will deliver a presentation on Tuesday, January 14, 2025, at 2:15 p.m. PT.
Investors can access a live audio webcast of the presentation through Ardent Health's investor relations website at ir.ardenthealth.com, with the recording remaining available for 90 days afterward. The management team will also be conducting one-on-one meetings with registered conference attendees, which can be arranged through J.P. Morgan representatives.
Ardent Health (NYSE: ARDT) announced that seven of its facilities have been named among Top Teaching Hospitals and Top Rural Hospitals by The Leapfrog Group, one of the most competitive healthcare awards in America. The recognized facilities include four Top Teaching Hospitals: Heart Hospital of New Mexico, Hillcrest Hospital South, Hillcrest Medical Center, and Seton Medical Center Harker Heights; and three Top Rural Hospitals: Hillcrest Hospital Pryor, UT Health Carthage, and UT Health Pittsburg.
Out of nearly 2,400 hospitals considered, only 134 were selected as Top Hospitals across different categories. The award evaluates various aspects of hospital performance, including infection rates, safer surgery practices, maternity care, and medication error prevention capabilities.
Ardent Health (NYSE: ARDT) announced that nine of its facilities earned an 'A' Hospital Safety Grade from The Leapfrog Group. The grades are based on over 30 performance measures related to patient safety. 81% of Ardent's eligible facilities earned an 'A' or 'B' grade, significantly outperforming the national average of 56%. The recognized facilities include medical centers in New Jersey, Oklahoma, Idaho, and Texas. The Leapfrog Hospital Safety Grade evaluates preventable medical errors, infections, and injuries, with grades updated biannually.
Ardent Health (NYSE: ARDT) reported strong Q3 2024 results with total revenue increasing 5.2% to $1.45 billion. Net income reached $26 million ($0.19 per share), while Adjusted EBITDA grew 15.3% to $98 million with margin expansion of 50bps to 6.7%. The company saw a 3.8% increase in adjusted admissions and 0.9% growth in net patient service revenue per adjusted admission. Based on strong performance, Ardent raised its full-year 2024 guidance, increasing the Adjusted EBITDA midpoint by 2% and improving revenue outlook to $5.8-5.875 billion.
Ardent Health (NYSE: ARDT) announced its management team's participation in three upcoming investor conferences. The team will attend the Stephens Annual Investment Conference on November 19 in Nashville, featuring a fireside chat at 10:00 a.m. ET, the Citi 2024 Global Healthcare Conference on December 3 in Miami, and the Bank of America Securities Leveraged Finance Conference on December 4 in Boca Raton.
Live audio webcasts of fireside discussions will be available on Ardent Health's Investor Relations website, with replays accessible for 90 days. The management team will also conduct one-on-one meetings with registered investors at each conference.